Literature DB >> 18337413

The mitochondrial protease AFG3L2 is essential for axonal development.

Francesca Maltecca1, Asadollah Aghaie, David G Schroeder, Laura Cassina, Benjamin A Taylor, Sandra J Phillips, Mariachiara Malaguti, Stefano Previtali, Jean-Louis Guénet, Angelo Quattrini, Gregory A Cox, Giorgio Casari.   

Abstract

The mitochondrial metalloprotease AFG3L2 assembles with the homologous protein paraplegin to form a supracomplex in charge of the essential protein quality control within mitochondria. Mutations of paraplegin cause a specific axonal degeneration of the upper motoneuron and, therefore, hereditary spastic paraplegia. Here we present two Afg3l2 murine models: a newly developed null and a spontaneous mutant that we found carrier of a missense mutation. Contrasting with the mild and late onset axonal degeneration of paraplegin-deficient mouse, Afg3l2 models display a marked impairment of axonal development with delayed myelination and poor axonal radial growth leading to lethality at P16. The increased severity of the Afg3l2 mutants is explained by two main molecular features that differentiate AFG3L2 from paraplegin: its higher neuronal expression and its versatile ability to support both hetero-oligomerization and homo-oligomerization. Our data assign to AFG3L2 a crucial role by linking mitochondrial metabolism and axonal development. Moreover, we propose AFG3L2 as an excellent candidate for motoneuron and cerebellar diseases with early onset unknown etiology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337413      PMCID: PMC6670688          DOI: 10.1523/JNEUROSCI.4677-07.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  37 in total

1.  Loss of the m-AAA protease subunit AFG₃L₂ causes mitochondrial transport defects and tau hyperphosphorylation.

Authors:  Arun Kumar Kondadi; Shuaiyu Wang; Sara Montagner; Nikolay Kladt; Anne Korwitz; Paola Martinelli; David Herholz; Michael J Baker; Astrid C Schauss; Thomas Langer; Elena I Rugarli
Journal:  EMBO J       Date:  2014-03-28       Impact factor: 11.598

2.  Early onset and slow progression of SCA28, a rare dominant ataxia in a large four-generation family with a novel AFG3L2 mutation.

Authors:  Ulf Edener; Janine Wöllner; Ute Hehr; Zacharias Kohl; Stefan Schilling; Friedmar Kreuz; Peter Bauer; Veronica Bernard; Gabriele Gillessen-Kaesbach; Christine Zühlke
Journal:  Eur J Hum Genet       Date:  2010-03-31       Impact factor: 4.246

3.  Non-syndromic isolated dominant optic atrophy caused by the p.R468C mutation in the AFG3 like matrix AAA peptidase subunit 2 gene.

Authors:  Davide Colavito; Veronica Maritan; Agnese Suppiej; Elda Del Giudice; Monica Mazzarolo; Stefania Miotto; Sofia Farina; Maurizio Dalle Carbonare; Stefano Piermarocchi; Alberta Leon
Journal:  Biomed Rep       Date:  2017-09-22

Review 4.  New roles for mitochondrial proteases in health, ageing and disease.

Authors:  Pedro M Quirós; Thomas Langer; Carlos López-Otín
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05-13       Impact factor: 94.444

5.  Unique Structural Features of the Mitochondrial AAA+ Protease AFG3L2 Reveal the Molecular Basis for Activity in Health and Disease.

Authors:  Cristina Puchades; Bojian Ding; Albert Song; R Luke Wiseman; Gabriel C Lander; Steven E Glynn
Journal:  Mol Cell       Date:  2019-07-18       Impact factor: 17.970

Review 6.  Mitochondrial Proteolysis and Metabolic Control.

Authors:  Sofia Ahola; Thomas Langer; Thomas MacVicar
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

7.  Genetic variation in ataxia gene ATXN7 influences cerebellar grey matter volume in healthy adults.

Authors:  Charlotte D C C van der Heijden; Mark Rijpkema; Alejandro Arias-Vásquez; Marina Hakobjan; Hans Scheffer; Guillen Fernandez; Barbara Franke; Bart P van de Warrenburg
Journal:  Cerebellum       Date:  2013-06       Impact factor: 3.847

Review 8.  Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

Authors:  Luisa Iommarini; Susana Peralta; Alessandra Torraco; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

9.  Mouse brain expression patterns of Spg7, Afg3l1, and Afg3l2 transcripts, encoding for the mitochondrial m-AAA protease.

Authors:  Tiziana Sacco; Enrica Boda; Eriola Hoxha; Riccardo Pizzo; Claudia Cagnoli; Alfredo Brusco; Filippo Tempia
Journal:  BMC Neurosci       Date:  2010-04-28       Impact factor: 3.288

10.  Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1.

Authors:  Sarah Ehses; Ines Raschke; Giuseppe Mancuso; Andrea Bernacchia; Stefan Geimer; Daniel Tondera; Jean-Claude Martinou; Benedikt Westermann; Elena I Rugarli; Thomas Langer
Journal:  J Cell Biol       Date:  2009-12-28       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.